Quinuclidine derivatives and medicinal compositions...

Details Quinuclidine derivatives and medicinal compositions... Quinuclidine derivatives and medicinal compositions...

2011-03-01

2011-03-01

Aulakh, Charanjit S (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S826000

Reexamination Certificate

active

07897617

ABSTRACT:
The invention provides 3-(2-hydroxy-2,2-dithien-2-ylacetoxy)-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2] octane in salt form, pharmaceutical compositions comprising it, and methods of using it for treatment of respiratory disorders, in association with steroids.

REFERENCES:
patent: 3714357 (1973-01-01), Gueremy et al.
patent: 4224332 (1980-09-01), Gueremy et al.
patent: 4644033 (1987-02-01), Gnanou et al.
patent: 4675326 (1987-06-01), Amitai et al.
patent: 4843074 (1989-06-01), Rzeszotarski et al.
patent: 5201308 (1993-04-01), Newhouse et al.
patent: 5435301 (1995-07-01), Herold et al.
patent: 5654314 (1997-08-01), Banholzer et al.
patent: 6455524 (2002-09-01), Bozung et al.
patent: 6475467 (2002-11-01), Keller et al.
patent: 6537524 (2003-03-01), Hassan et al.
patent: 6686346 (2004-02-01), Nilsson et al.
patent: 6750226 (2004-06-01), Forner et al.
patent: 7078412 (2006-07-01), Fernandez Forner et al.
patent: 7109210 (2006-09-01), Forner et al.
patent: 7196098 (2007-03-01), Fernandez Forner et al.
patent: 7214687 (2007-05-01), Fernandez Forner et al.
patent: 7750023 (2010-07-01), Fernandez Forner et al.
patent: 2002/0193392 (2002-12-01), Schmelzer et al.
patent: 2003/0018019 (2003-01-01), Meade et al.
patent: 2004/0176338 (2004-09-01), Pairet et al.
patent: 2005/0025718 (2005-02-01), Meade et al.
patent: 2005/0026886 (2005-02-01), Meade et al.
patent: 2005/0026887 (2005-02-01), Meade et al.
patent: 2005/0026948 (2005-02-01), Meade et al.
patent: 2005/0209272 (2005-09-01), Forner et al.
patent: 2005/0267078 (2005-12-01), Gras et al.
patent: 2005/0267135 (2005-12-01), Escardo et al.
patent: 2005/0288266 (2005-12-01), Gras et al.
patent: 0424021 (1994-03-01), None
patent: 0418716 (1994-04-01), None
patent: 0747355 (1996-12-01), None
patent: 0801067 (1997-10-01), None
patent: 1087750 (2001-04-01), None
patent: 1763369 (2008-12-01), None
patent: 2012964 (1970-03-01), None
patent: 1219606 (1971-01-01), None
patent: 178679 (1982-06-01), None
patent: WO 91/04252 (1991-04-01), None
patent: WO 92/04345 (1992-03-01), None
patent: WO 96/32150 (1996-10-01), None
patent: WO 00/47200 (2000-08-01), None
patent: WO 01/04118 (2001-01-01), None
patent: WO 01/50080 (2001-07-01), None
patent: WO 01/78736 (2001-10-01), None
patent: WO 01/78739 (2001-10-01), None
patent: WO 01/78741 (2001-10-01), None
patent: WO 01/78743 (2001-10-01), None
patent: WO 02/36106 (2002-05-01), None
patent: WO 02/38154 (2002-05-01), None
patent: WO 02/47667 (2002-06-01), None
patent: WO 02/053564 (2002-07-01), None
patent: WO 02/060532 (2002-08-01), None
patent: WO 02/060533 (2002-08-01), None
patent: WO 03/000241 (2003-01-01), None
patent: WO 03/087094 (2003-10-01), None
patent: WO 03/097613 (2003-11-01), None
patent: WO 2004/043966 (2004-05-01), None
patent: WO 2004/058729 (2004-07-01), None
patent: WO 2005/014005 (2005-02-01), None
patent: WO 2005/049581 (2005-06-01), None
patent: WO 2005/115466 (2005-12-01), None
Ayres, J.G. et al., Thorax (1997) 52 (Suppl 1):S1-S21.
EPO Application No. 04763322.7-2123, Third Party Observations dated Jul. 8, 2008.
EP Patent No. 1 763 369, Notice of Opposition dated Sep. 15, 2009 (with English Translation).
Laboratorios Almirall S.A.v.Boehringer Ingelheim International Gmbh(2009) EWHC (CH) (Patent) HC 07 C0 2104 (Eng.); English High Court Judgment.
Schelfhout, et al., Activity of LAS 34273, a new long acting anticholinergic antagonist, poster. ATS 2003—99thInternational Conference May 2003.
Schelfhout, et al., Activity of LAS 34273, a new long acting anticholinergic antagonist, in COPD patients, poster. ATS 2003—99thInternational Conference May 2003.
U.S. Appl. No. 10/892,033, Office Action dated Oct. 2, 2007.
U.S. Appl. No. 10/892,033, Office Action Response dated Apr. 2, 2008.
U.S. Appl. No. 10/892,033, Appeal Brief dated Aug. 30, 2010.
Atrovent (ipratropium bromide) Inhalation Solution Prescribing Information, Boehringer Ingelheim International GmbH, Revised Oct. 1998 830885-R.
Atrovent® Inhalation Aerosol Prescribing Information, Boehringer Ingelheim International GmbH, 10001403/US/1, 10001403/01, revised Mar. 27, 2002.
Burtner, R., et al., “Antispasmodics, II. Basic Esters of Some Polynuclear Carboxylic Acids,” J. Am. Chem. Soc. vol. 65. pp. 1582-1585 (1943).
Chronic Obstructive Airway Disorders, Merck Manual, p. 656 (17th ed., 1997).
Cohen et al., Synthesis and Receptor Affinities of New 3-Quinuclidinyl a-Heteroaryl-a-aryl-a-hydroxyacetates, Journal of Pharmaceutical Sciences, vol. 81, No. 4, 326-29, Apr. 1992.
Combivent® Inhalation Aerosol Prescribing Information, Boehringer Ingelheim International GmbH, 10000291/03, revised Sep. 2001.
Costain, D., et al., “Guidelines for Management of Asthma in Adults: I—Chronic Persistent Asthma,” Br. Med. J. (1990) 301, 651-653.
Davis, M.A., et al., “Anticonvulsants. I. Dibenzo[a,d]cycloheptadiene-5-carboxamide and Related Compounds,” J. Med. Chem. vol. 7, pp. 88-94, (1964).
Davis, M.A., et al., “New Psychotropic Agents. VI. Basic Esters of 5-Hydroxydibenzo[a,d]cycloheptadiene-5-carboxylic Acid,” J. Med. Chem, vol. 6, pp. 513-516, (1963).
Elgen et al., Muscarinic Receptor Subtypes; Pharmacology and Therapeutic Potential, DN&P 01(8):462469 (Orcober 1997).
Foye et al., Principles of Medicinal Chemistry, 4th ed., 338-340 (1995).
Gao, S-H., et al. Stereochemistry of the heterocyclic alcohols containing piperidine unit, Gaodeng Xuexiao Huaxue Xuebao, 1999, pp. 232-236, vol. 20.
Godoviko et al., Synthesis and Muscarinolytic Activity of Quinuclidinyl Benzylate Iodoalkylates, Pharmaceutical Chemistry Journal, vol. 19, No. 9, 602-604 (1985).
Grob, C.A., et al., “Die Synthese von 4-Brom- und 4-Hydroxy-Chinuclidin,” Helv. Chem. Acta, vol. 41, pp. 1184-1191, (1958).
Hancox, R.J., et al., “Randomised trial of an inhaled B2 agonist, inhaled corticosteroid and their combination in the treatment of asthma,” Thorax, vol. 54, pp. 482-487, (1999).
Heacock, R.A., et al., “Materials and Methods,” The Annals of Applied Biology, Marsh, R.W. and Thomas, I., eds, Cambridge at the University Press, vol. 46, pp. 356-365, (1958).
Konzett, H., et al., “Versuchsanordnung zu Untersuchungnen an der Bronchialmuskulatur,” Arch. Exp. Path. Pharmacol., vol. 195, pp. 71-74, (1940).
Kumazawa, T., et al., “Inhibitors of Acyl-CoA: Cholesterol Acyltransferase. 1. Synthesis and Hypocholesterolemic Activity of Dibenz[b,e]oxepin-11carboxanilides,” J. Med. Chem., vol. 37(6), pp. 804-810, (1994).
Larsson et al., The hydrogen bond condition in some anticholinergic esters of glycolic acids. I, ACTA Pharm. Suecica 11, 304-308 (1974).
Martin, L., “Drugs for Asthma/COPD—A Medical Primer for Physicians,” http://www.lakesidepress.com/pulmonary/Asthma-Rx.html (updated Feb. 1999).
Martindale the Complete Drug Reference (Kathleen Parfitt ed., 32nd ed., 1999) pp. 745-747.
May, E.L., et al., “Studies in the Anthracene Series. V. A Novel Rearrangement in the Reaction of Halomethyl Ketones with Secondary Amines,” J. Am. Chem. Soc., vol. 70, pp. 1077-1079, (1948).
Meyers, A.I., et al., “Resolution of a-Substituted Mandelic Acids via Chiral Oxazolines Using Pressurized Chromatography,” J. Org. Chem., vol. 45(14), pp. 2912-2914, (1980).
Naronha-Blob, L., et al. Stereoselective antimuscarinic effects of 3-quinuclidinyl atrolactate and 3-quinuclidinyl xanthene-9-carboxylate, 1992, pp. 97-103, vol. 211.
Nishimura, et al., “Additive effect of oxitropium bromide in combination with inhaled corticosteroids in the treatment of elderly patients with chronic asthma,” Allerology International, vol. 48, pp. 85-88, (1999).
Nyberg et al., Investigations of Dithienylglycol Esters, ACTA Chemica Scandinavica 24 (1973) No. 5, 1590-96.
Pearson, et al., Thorax 52(Suppl 5), S1-S28, (1997).
Rang, H.P. et al., Pharmacology (Churchill Livingston Inc., 1995) pp. 358-361.
Rees, P.J., “Bronchodilators in the therapy of chronic obstructive pulmonary disease,” Eur Respir Mon, vol. 7, pp. 135-149,

Affiliated with

Also associated with

Rating

Quinuclidine derivatives and medicinal compositions... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Quinuclidine derivatives and medicinal compositions..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinuclidine derivatives and medicinal compositions... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2755304